Literature DB >> 1933711

Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. 1922.

F G Banting, C H Best, J B Collip, W R Campbell, A A Fletcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1933711      PMCID： PMC1335942     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

Review 1.  Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence.

Authors:  Israel Hartman
Journal:  Clin Med Res       Date:  2008-09-18

Review 2.  Revisiting amino acids and peptides as anti-glycation agents.

Authors:  H Chilukuri; M J Kulkarni; M Fernandes
Journal:  Medchemcomm       Date:  2018-02-12       Impact factor: 3.597

Review 3.  Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.

Authors:  Yukako Ohyama; Kazuki Nakajima; Matthew B Renfrow; Jan Novak; Kazuo Takahashi
Journal:  Expert Rev Proteomics       Date:  2020-05-28       Impact factor: 3.940

Review 4.  Pancreas transplantation in type II diabetes mellitus.

Authors:  Phillip Weems; Matthew Cooper
Journal:  World J Transplant       Date:  2014-12-24

5.  Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model.

Authors:  Benjamin K Nti; Janet L Markman; Suzanne Bertera; Alexis J Styche; Robert J Lakomy; Vladimir M Subbotin; Massimo Trucco; Tatiana D Zorina
Journal:  Cell Mol Immunol       Date:  2012-10-08       Impact factor: 11.530

6.  Efficient and simple production of insulin-producing cells from embryonal carcinoma stem cells using mouse neonate pancreas extract, as a natural inducer.

Authors:  Marzieh Ebrahimie; Fariba Esmaeili; Somayeh Cheraghi; Fariba Houshmand; Leila Shabani; Esmaeil Ebrahimie
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 7.  Next generation delivery system for proteins and genes of therapeutic purpose: why and how?

Authors:  Ashish Ranjan Sharma; Shyamal Kumar Kundu; Ju-Suk Nam; Garima Sharma; C George Priya Doss; Sang-Soo Lee; Chiranjib Chakraborty
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

8.  Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women.

Authors:  Kim M Huffman; Svati H Shah; Robert D Stevens; James R Bain; Michael Muehlbauer; Cris A Slentz; Charles J Tanner; Maragatha Kuchibhatla; Joseph A Houmard; Christopher B Newgard; William E Kraus
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

Review 9.  Zebrafish and Flavonoids: Adjuvants against Obesity.

Authors:  Giuseppe Montalbano; Kamel Mhalhel; Marilena Briglia; Maria Levanti; Francesco Abbate; Maria Cristina Guerrera; Enrico D'Alessandro; Rosaria Laurà; Antonino Germanà
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

10.  The need to reform our assessment of evidence from clinical trials: a commentary.

Authors:  Sean M Bagshaw; Rinaldo Bellomo
Journal:  Philos Ethics Humanit Med       Date:  2008-09-30       Impact factor: 2.464
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.